Cost of peripheral neuropathy in patients receiving treatment for multiple myeloma: a US administrative claims analysis

BACKGROUND: Peripheral neuropathy (PN) is a common consequence of multiple myeloma (MM) among those commonly treated with older-generation proteasome inhibitors (PIs). In this study, we evaluated the economic burden attributable to PN among MM patients in real-world practice settings in the US. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Xue, Wilson, Kathleen L., Kagan, Jerry, Panjabi, Sumeet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444783/
https://www.ncbi.nlm.nih.gov/pubmed/30967926
http://dx.doi.org/10.1177/2040620719839025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444783/
https://www.ncbi.nlm.nih.gov/pubmed/30967926
http://dx.doi.org/10.1177/2040620719839025

Ejemplares similares